Jacques Pirenne

Author PubWeight™ 90.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009 5.26
2 Intrarenal resistive index after renal transplantation. N Engl J Med 2013 4.19
3 Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology 2012 2.49
4 Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2011 2.36
5 Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int 2011 2.25
6 Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut 2013 2.10
7 Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013 1.93
8 Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002 1.79
9 Congenital veno-venous malformations of the liver: widely variable clinical presentations. J Gastroenterol Hepatol 2007 1.68
10 The histology of kidney transplant failure: a long-term follow-up study. Transplantation 2014 1.61
11 Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation 2016 1.59
12 Troponin I is a predictor of acute cardiac events in the immediate postoperative renal transplant period. Transplantation 2010 1.45
13 Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease. Hepatology 2011 1.43
14 Lipid peroxidation products in machine perfusion of older donor kidneys. J Surg Res 2012 1.42
15 Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol 2012 1.42
16 The extent of vacuolation in non-heart-beating porcine donor liver grafts prior to transplantation predicts their viability. Liver Transpl 2008 1.41
17 Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 2009 1.38
18 Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 2006 1.32
19 Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion 2007 1.31
20 Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2012 1.26
21 Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int 2006 1.24
22 Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg 2006 1.20
23 Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial. Ann Surg 2010 1.17
24 MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int 2007 1.13
25 The balance of risk score for allocation in liver transplantation. Ann Surg 2014 1.11
26 Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients. Clin Pharmacokinet 2004 1.06
27 A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer 2010 1.06
28 Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 2005 1.01
29 Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation 2008 0.96
30 Liver transplantation using Donation after Cardiac Death donors. J Hepatol 2011 0.92
31 Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma 2013 0.90
32 The predictive value of kidney allograft baseline biopsies for long-term graft survival. J Am Soc Nephrol 2013 0.89
33 The unrecognized posterior gastric artery: a potential cause of surgical complications in pancreas transplantation. Clin Transplant 2004 0.89
34 Circulating AST, H-FABP, and NGAL are early and accurate biomarkers of graft injury and dysfunction in a preclinical model of kidney transplantation. Ann Surg 2011 0.89
35 The value of machine perfusion perfusate biomarkers for predicting kidney transplant outcome. Transplantation 2010 0.88
36 Machine perfusion versus cold storage for the preservation of kidneys from donors ≥ 65 years allocated in the Eurotransplant Senior Programme. Nephrol Dial Transplant 2012 0.87
37 Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 2006 0.86
38 Graft quality assessment in kidney transplantation: not an exact science yet! Curr Opin Organ Transplant 2011 0.86
39 Livers from non-heart-beating donors tolerate short periods of warm ischemia. Transplantation 2005 0.86
40 The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder. Haematologica 2012 0.85
41 Giant liver hemangioma: the role of female sex hormones and treatment. Eur J Gastroenterol Hepatol 2011 0.85
42 The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation. Transplantation 2008 0.85
43 Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation 2011 0.84
44 Are TIPS stent-grafts a contraindication for future liver transplantation? Cardiovasc Intervent Radiol 2004 0.84
45 Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity. Ann Surg 2009 0.84
46 Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007. Transpl Int 2009 0.83
47 From vascular corrosion cast to electrical analog model for the study of human liver hemodynamics and perfusion. IEEE Trans Biomed Eng 2010 0.83
48 Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs. Liver Transpl 2007 0.83
49 Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection. J Hepatol 2003 0.83
50 Preserving the morphology and evaluating the quality of liver grafts by hypothermic machine perfusion: a proof-of-concept study using discarded human livers. Liver Transpl 2012 0.83
51 Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients. Transplantation 2009 0.83
52 Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature. Transpl Int 2010 0.82
53 Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Liver Transpl 2008 0.82
54 Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusion. J Immunol 2005 0.81
55 Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. Am J Transplant 2002 0.81
56 Kidney donation after circulatory death in a country with a high number of brain dead donors: 10-year experience in Belgium. Transpl Int 2012 0.81
57 Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update. Leuk Lymphoma 2011 0.80
58 Artificial circulation of the liver: machine perfusion as a preservation method in liver transplantation. Anat Rec (Hoboken) 2008 0.80
59 Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells? Curr Opin Organ Transplant 2013 0.79
60 Machine perfusion versus static cold storage in expanded criteria donor kidney transplantation: 3-year follow-up data. Transpl Int 2013 0.79
61 Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation. Eur J Gastroenterol Hepatol 2010 0.79
62 Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg 2013 0.79
63 Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy? Transplantation 2004 0.79
64 The Efficacy of Noble Gases in the Attenuation of Ischemia Reperfusion Injury: A Systematic Review and Meta-Analyses. Crit Care Med 2016 0.78
65 Assessing warm ischemic injury of pig livers at hypothermic machine perfusion. J Surg Res 2013 0.78
66 Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature. Transpl Int 2013 0.78
67 Histology obtained by needle biopsy gives additional information on the prognosis of hepatocellular carcinoma. Hepatol Res 2012 0.78
68 Post-serial transverse enteroplasty bowel redilatation treated by longitudinal intestinal lengthening and tailoring procedure. J Pediatr Surg 2012 0.78
69 Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation 2003 0.78
70 Intestinal failure: autologous reconstruction, intestinal transplantation and intestinal ischemia reperfusion injury. Curr Opin Organ Transplant 2013 0.78
71 Decision making in pretransplant nephrectomy for polycystic kidneys, is it valid for horseshoe kidneys? Transpl Int 2012 0.78
72 Flow competition between hepatic arterial and portal venous flow during hypothermic machine perfusion preservation of porcine livers. Int J Artif Organs 2012 0.78
73 Renal cell carcinoma in the allograft: what is the role of polyomavirus? Case Rep Nephrol Urol 2012 0.77
74 Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial. Transpl Int 2006 0.77
75 FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. Transplantation 2003 0.77
76 Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 2005 0.77
77 Machine perfusion in clinical trials: "machine vs. solution effects". Transpl Int 2012 0.77
78 Heterozygous α1-antitrypsin Z allele mutation in presumed healthy donor livers used for transplantation. Eur J Gastroenterol Hepatol 2013 0.77
79 Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry. Transplantation 2016 0.77
80 Paradoxical early upregulation of intragraft Th1 cytokines is associated with graft acceptance following donor-specific blood transfusion. Transpl Int 2003 0.76
81 Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Transplantation 2017 0.76
82 Time to think out of the (ice) box. Curr Opin Organ Transplant 2010 0.75
83 Left ventricular assist device as bridge to liver transplantation in a patient with propionic acidemia and cardiogenic shock. J Pediatr 2011 0.75
84 Organ Procurement and Transplantation in Belgium. Transplantation 2017 0.75
85 Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation. Transplantation 2017 0.75
86 Should the law on anonymity of organ donation be changed? The perception of liver transplant recipients. Clin Transplant 2009 0.75
87 Cessation of steroids in stable renal transplant patients: the Leuven experience. Clin Transpl 2002 0.75
88 Portal hypertension after combined liver and intestinal transplantation, a diagnostic and therapeutic challenge? Pediatr Transplant 2012 0.75
89 An uncommon tumor in a renal graft recipient: a diagnostic and therapeutic challenge. Am J Kidney Dis 2002 0.75
90 Improving the function of liver grafts exposed to warm ischemia by the Leuven drug protocol: exploring the molecular basis by microarray. Liver Transpl 2012 0.75
91 Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results. Ann Surg 2017 0.75
92 Implementation of an intervention plan designed to optimize donor referral in a donor hospital network. Prog Transplant 2006 0.75
93 HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY. Transplantation 2016 0.75
94 Infrarenal origin of the superior mesenteric artery challenges the procurement surgeon. Transpl Int 2014 0.75
95 Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature. Transpl Int 2002 0.75
96 Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry. Transplantation 2017 0.75
97 Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation. Transplantation 2015 0.75
98 Intestinal ischemia reperfusion and lipopolysaccharide transform a tolerogenic signal into a sensitizing signal and trigger rejection. Transplantation 2009 0.75
99 Reducing Non-Anastomotic Biliary Strictures in Donation After Circulatory Death Liver Transplantation: Cold Ischemia Time Matters! Ann Surg 2017 0.75
100 "Model for Early Allograft Function" outperforms "Early Allograft Dysfunction" as a predictor of transplant survival. Transplantation 2017 0.75
101 Adult Liver Allocation in Eurotransplant. Transplantation 2017 0.75
102 Plasmatic villin 1 is a novel in vivo marker of proximal tubular cell injury during renal ischemia-reperfusion. Transplantation 2017 0.75
103 The effect of FTY 720 on engraftment in a model of spontaneous allograft acceptance. Transpl Int 2003 0.75
104 Alpers syndrome presenting with anatomopathological features of fulminant autoimmune hepatitis. J Inherit Metab Dis 2010 0.75